Display options
Share it on

Int J Pept. 2012;2012:452524. doi: 10.1155/2012/452524. Epub 2012 Oct 18.

Diet-induced obesity in mice overexpressing neuropeptide y in noradrenergic neurons.

International journal of peptides

Suvi T Ruohonen, Laura H Vähätalo, Eriika Savontaus

Affiliations

  1. Department of Pharmacology, Drug Development, and Therapeutics and Turku Center for Disease Modeling, University of Turku, Itäinen Pitkäkatu 4B, 20520 Turku, Finland.

PMID: 23118773 PMCID: PMC3483820 DOI: 10.1155/2012/452524

Abstract

Neuropeptide Y (NPY) is a neurotransmitter associated with feeding and obesity. We have constructed an NPY transgenic mouse model (OE-NPY(DBH) mouse), where targeted overexpression leads to increased levels of NPY in noradrenergic and adrenergic neurons. We previously showed that these mice become obese on a normal chow. Now we aimed to study the effect of a Western-type diet in OE-NPY(DBH) and wildtype (WT) mice, and to compare the genotype differences in the development of obesity, insulin resistance, and diabetes. Weight gain, glucose, and insulin tolerance tests, fasted plasma insulin, and cholesterol levels were assayed. We found that female OE-NPY(DBH) mice gained significantly more weight without hyperphagia or decreased activity, and showed larger white and brown fat depots with no difference in UCP-1 levels. They also displayed impaired glucose tolerance and decreased insulin sensitivity. OE-NPY(DBH) and WT males gained weight robustly, but no difference in the degree of adiposity was observed. However, 40% of OE-NPY(DBH) but none of the WT males developed hyperglycaemia while on the diet. The present study shows that female OE-NPY(DBH) mice were not protected from the obesogenic effect of the diet suggesting that increased NPY release may predispose females to a greater risk of weight gain under high caloric conditions.

References

  1. Exp Clin Endocrinol Diabetes. 2006 Apr;114(4):147-52 - PubMed
  2. Endocrinology. 1996 Jan;137(1):21-9 - PubMed
  3. Diabetes. 2005 Sep;54(9):2628-37 - PubMed
  4. Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15659-64 - PubMed
  5. FASEB J. 2004 Jan;18(1):137-9 - PubMed
  6. Am J Physiol Endocrinol Metab. 2006 Feb;290(2):E396-403 - PubMed
  7. Neuroendocrinology. 2009;89(3):351-60 - PubMed
  8. Endocrinology. 1995 Dec;136(12):5547-54 - PubMed
  9. Diabetes. 2008 Jun;57(6):1517-25 - PubMed
  10. Endocrinology. 1993 Oct;133(4):1753-8 - PubMed
  11. Nat Med. 1998 Dec;4(12):1434-7 - PubMed
  12. Microvasc Res. 2010 Dec;80(3):433-9 - PubMed
  13. Proc Natl Acad Sci U S A. 1995 May 23;92(11):4728-32 - PubMed
  14. Endocrinology. 2008 Apr;149(4):1609-17 - PubMed
  15. Regul Pept. 2008 Aug 7;149(1-3):51-5 - PubMed
  16. Peptides. 2009 Apr;30(4):715-20 - PubMed
  17. Int J Obes (Lond). 2010 Feb;34(2):357-73 - PubMed
  18. J Neurosci. 2008 Dec 31;28(53):14428-34 - PubMed
  19. J Clin Invest. 1994 May;93(5):2007-13 - PubMed
  20. Diabetes. 2006 Nov;55(11):3091-8 - PubMed
  21. FASEB J. 2002 May;16(7):712-4 - PubMed
  22. Philos Trans R Soc Lond B Biol Sci. 2006 Jul 29;361(1471):1159-85 - PubMed
  23. Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E356-67 - PubMed
  24. Endocrinology. 1994 Jun;134(6):2367-70 - PubMed
  25. Nat Med. 2007 Jul;13(7):803-11 - PubMed
  26. Obes Res. 2005 Apr;13(4):653-61 - PubMed
  27. Nature. 1997 May 1;387(6628):90-4 - PubMed
  28. FASEB J. 2001 May;15(7):1242-4 - PubMed
  29. Eur J Clin Nutr. 2009 Jan;63(1):150-2 - PubMed
  30. Am J Physiol Endocrinol Metab. 2008 Oct;295(4):E981-6 - PubMed

Publication Types